Hallmarks of cancer: the next generation
- PMID: 21376230
- DOI: 10.1016/j.cell.2011.02.013
Hallmarks of cancer: the next generation
Abstract
The hallmarks of cancer comprise six biological capabilities acquired during the multistep development of human tumors. The hallmarks constitute an organizing principle for rationalizing the complexities of neoplastic disease. They include sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis. Underlying these hallmarks are genome instability, which generates the genetic diversity that expedites their acquisition, and inflammation, which fosters multiple hallmark functions. Conceptual progress in the last decade has added two emerging hallmarks of potential generality to this list-reprogramming of energy metabolism and evading immune destruction. In addition to cancer cells, tumors exhibit another dimension of complexity: they contain a repertoire of recruited, ostensibly normal cells that contribute to the acquisition of hallmark traits by creating the "tumor microenvironment." Recognition of the widespread applicability of these concepts will increasingly affect the development of new means to treat human cancer.
Copyright © 2011 Elsevier Inc. All rights reserved.
Similar articles
-
Rho GTPases modulate malignant transformation of tumor cells.Small GTPases. 2014;5:e29019. doi: 10.4161/sgtp.29019. Epub 2014 May 8. Small GTPases. 2014. PMID: 25036871 Free PMC article. Review.
-
The contribution of tumour-derived exosomes to the hallmarks of cancer.Crit Rev Clin Lab Sci. 2016;53(2):121-31. doi: 10.3109/10408363.2015.1092496. Epub 2015 Oct 19. Crit Rev Clin Lab Sci. 2016. PMID: 26479834 Review.
-
Hallmarks of Cancers: Primary Antibody Deficiency Versus Other Inborn Errors of Immunity.Front Immunol. 2021 Aug 17;12:720025. doi: 10.3389/fimmu.2021.720025. eCollection 2021. Front Immunol. 2021. PMID: 34484227 Free PMC article. Review.
-
Tumor-stroma crosstalk: targeting stroma in breast cancer.Curr Opin Oncol. 2014 Nov;26(6):551-5. doi: 10.1097/CCO.0000000000000122. Curr Opin Oncol. 2014. PMID: 25279962 Review.
-
Long non-coding RNAs in cancer: Another layer of complexity.J Gene Med. 2019 Jan;21(1):e3065. doi: 10.1002/jgm.3065. Epub 2019 Jan 8. J Gene Med. 2019. PMID: 30549380 Review.
Cited by
-
Oncolytic virotherapy against lung cancer: key receptors and signaling pathways of viral entry.Front Immunol. 2024 Oct 4;15:1473288. doi: 10.3389/fimmu.2024.1473288. eCollection 2024. Front Immunol. 2024. PMID: 39430750 Free PMC article. Review.
-
Assessing the Prognostic Value of 13 Inflammation-Based Scores in Patients with Unresectable or Advanced Biliary Tract Carcinoma After Immunotherapy.Immunotargets Ther. 2024 Oct 16;13:541-557. doi: 10.2147/ITT.S471502. eCollection 2024. Immunotargets Ther. 2024. PMID: 39431245 Free PMC article.
-
Advanced lung cancer inflammation index is associated with prognosis in skin cancer patients: a retrospective cohort study.Front Oncol. 2024 Oct 11;14:1365702. doi: 10.3389/fonc.2024.1365702. eCollection 2024. Front Oncol. 2024. PMID: 39464703 Free PMC article.
-
Analysis of Risk Factors with Assessment of the Impact of the Microbiome on the Risk of Squamous Cell Carcinoma of the Larynx.J Clin Med. 2024 Oct 13;13(20):6101. doi: 10.3390/jcm13206101. J Clin Med. 2024. PMID: 39458051 Free PMC article.
-
Evaluating Circulating Biomarkers for Diagnosis, Prognosis, and Tumor Monitoring in Pediatric Sarcomas: Recent Advances and Future Directions.Biomolecules. 2024 Oct 16;14(10):1306. doi: 10.3390/biom14101306. Biomolecules. 2024. PMID: 39456239 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases